Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by Boomskidon Feb 23, 2023 1:49pm
191 Views
Post# 35301386

Some shareholders...

Some shareholders...I'd like to know, as some others do, whether any shareholders will benefit more than others if Bioasis is sold off to Midatech or to some other entity.

Are there any shareholders who have agreed to vote their shares in support of scenarios in which will they benefit in some way by sticking with the buying company, and have they agreed to keep quiet about it all?

Things have been so weird for the last 15 to 18 months, and some shareholders are acting so weird, that questions are obvious.

And, of course, if any shareholders have made agreements for their support, with whom did they make the agreements, the sellers, the buyers, or both?

What's the silence all about? Why is there such an apparent lack of passion and outrage? How did the entire AGM agenda get approved after the company had just taken a tumble from 17¢ to 3¢, and a tumble to 1¢ today?

We've all seen and been part of stock market failures, but I've never seen one with such a high potential, whose IP has never failed and that can be a part of such a huge commercial space, that is failing with no visible wounds or illness, other than that mommy doesn't appear to be feeding it.

Are there shareholders who have sold out, or have they simply given up? I'm sick of it all, too, but there are still some battles to wage. And I'm not naming anybody, so I'm not making allegations. I'm asking questions about some things that are difficult to explain.

jd
<< Previous
Bullboard Posts
Next >>